Position in BIOA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$25,036,082
+$10,153,946 QoQ
Shares Held
1,021,464
+20.0% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 151 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $7,768,199,773 across 50 Drug Manufacturers - Specialty & Generic names. BIOA ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
19,667,723 | $1,413,322,574 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,898,064 | $1,028,428,017 | |
| 3 | VTRS |
Viatris Inc
|
53,069,461 | $842,743,040 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
4,385,598 | $739,148,686 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,936,548 | $641,570,246 | |
| 6 | ALKS |
Alkermes plc.
|
9,160,575 | $480,014,130 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
16,063,046 | $395,311,562 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
8,145,699 | $282,411,384 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,036,082 | 1,021,464 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $14,882,136 | 850,894 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,594,252 | 422,846 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,164,892 | 198,111 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $664,306 | 160,849 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $394,160 | 104,830 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $274,498 | 47,409 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||